Louisiana 2022 Regular Session

Louisiana House Bill HB698

Introduced
3/4/22  
Introduced
3/4/22  
Refer
3/4/22  
Refer
3/4/22  
Refer
3/14/22  
Refer
3/14/22  
Report Pass
4/19/22  
Engrossed
5/3/22  
Refer
5/4/22  
Refer
5/4/22  
Report Pass
5/18/22  
Enrolled
6/6/22  
Chaptered
6/16/22  
Chaptered
6/16/22  
Passed
6/16/22  

Caption

Provides for fees and charges to be assessed by the La. Department of Health in connection with regulation of marijuana for therapeutic use (EN NO IMPACT SG RV See Note)

Impact

The implementation of HB 698 would significantly impact state laws concerning the regulation of marijuana, especially regarding the legal frameworks governing its therapeutic use. The assessment of fees aims to not only facilitate the regulatory responsibilities of the Department of Health but also to incorporate financial incentives that may enhance compliance and oversight. The bill is positioned to align Louisiana’s marijuana policies with broader health regulations, thereby streamlining procedures and potentially improving access for patients needing therapeutic marijuana.

Summary

House Bill 698 primarily focuses on the regulation of marijuana for therapeutic use by the Louisiana Department of Health. The bill outlines the framework for assessing fees and charges related to this regulation, aiming to create a structured system that governs the therapeutic use of marijuana. Proponents of the bill see it as a beneficial addition to health policies, contributing to the state's approach towards managing marijuana in a manner consistent with public health objectives. By establishing fees, the bill seeks to ensure that the regulatory process is adequately funded and managed by the state's health department.

Sentiment

The general sentiment around HB 698 appears to be positive among supporters, who argue that it represents a responsible and necessary step towards regulating therapeutic marijuana within the state. Their view is that such regulation can lead to greater public health outcomes and a well-coordinated approach to marijuana use. However, there may be dissent among various stakeholders concerned with the implications of state-regulated fees and the access these may afford to patients seeking therapeutic marijuana. The balance between regulation and access is a key theme in the discussions surrounding the bill.

Contention

Notable points of contention regarding HB 698 may revolve around the practical implications of the fees imposed and how they might affect patient access to therapeutic marijuana. Some critics may argue that fees could create barriers for patients who need these treatments but are unable to afford the associated costs. Furthermore, discussions could emerge regarding the authority of the Department of Health in regulating this new area and whether the bill adequately protects the interests of patients while ensuring proper oversight of marijuana use.

Companion Bills

No companion bills found.

Previously Filed As

LA HB657

Provides relative to fees collected by the Louisiana Department of Health related to the sale of therapeutic marijuana (EN +$225,000 SG RV See Note)

LA HB661

Provides relative to fees collected by the Louisiana Department of Health

LA HB627

Provides for the Louisiana Cannabis Pilot Program (OR INCREASE SG RV See Note)

LA HB373

Provides for the Louisiana Cannabis Pilot Program (OR INCREASE SG RV See Note)

LA HB758

Provides with respect to the Department of Environmental Quality fees (EN +$12,383,369 SG RV See Note)

LA SB465

Provides for payments to healthcare providers. (8/1/26) (EN NO IMPACT See Note)

LA SB128

Provides relative to authorized changes of address by the Department of Revenue. (gov sig) (EN NO IMPACT SG EX See Note)

LA SB270

Provides for access to medical marijuana for terminally ill patients in a healthcare facility. (8/1/26)

LA HB644

Provides for the assessment of a fee for filing civil and criminal matters (EN +$694,384 SG RV See Note)

LA HB183

Provides for the inspection of assessment lists, challenges to the correctness of assessments, and reviews by boards of review and the La Tax Commission (EG NO IMPACT See Note)

Similar Bills

LA HB657

Provides relative to fees collected by the Louisiana Department of Health related to the sale of therapeutic marijuana (EN +$225,000 SG RV See Note)

LA HB661

Provides relative to fees collected by the Louisiana Department of Health

LA HB627

Provides for the Louisiana Cannabis Pilot Program (OR INCREASE SG RV See Note)

LA HB373

Provides for the Louisiana Cannabis Pilot Program (OR INCREASE SG RV See Note)

LA SB270

Provides for access to medical marijuana for terminally ill patients in a healthcare facility. (8/1/26)

LA HB460

Provides relative to employment discrimination against certain employees being treated with medical marijuana